A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes
Clinical trial NCT04509193 · COMPLETED
Trial details
- NCT number
- NCT04509193
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-21
- Primary completion
- 2021-07-31
- Enrollment
- 116049
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.